Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (27)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Fonck, C.
Right arrow Articles by Grünfeld, J.-P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fonck, C.
Right arrow Articles by Grünfeld, J.-P.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrol Dial Transplant (2001) 16: 1648-1652
© 2001 European Renal Association-European Dialysis and Transplant Association

Autosomal recessive polycystic kidney disease in adulthood

Catherine Fonck1,3, Dominique Chauveau1,, Marie-France Gagnadoux2, Yves Pirson3 and Jean-Pierre Grünfeld1

1 Service de Néphrologie and Inserm U 507, 2 Service de Néphrologie Pédiatrique, Hôpital Necker–Enfants Malades, Paris, France and 3 Service de Néphrologie, Cliniques Universitaires Saint-Luc, Brussels, Belgium

Background. Renal cysts arising from collecting ducts, congenital hepatic fibrosis, and recessive inheritance characterize autosomal recessive polycystic kidney disease (ARPKD). The disorder usually manifests in infancy, with a high mortality rate in the first year of life. For the patients who survive the neonatal period, the probability of being alive at 15 years of age ranges from 50 to 80%, with 56–67% of them not requiring renal replacement therapy at that stage. Some develop portal hypertension. Long-term outcome of adults escaping renal insufficiency above age 18 is largely unknown.

Method. In consecutive patients with ARPKD and autonomous renal function at age 18, clinical course of kidney and liver disease in adulthood and status at last follow-up were evaluated. Progression of renal insufficiency was assessed by the rate of decline of creatinine clearance, according to Schwartz's formula before age 18 and Cockcroft and Gault formula thereafter. Severity of liver involvement was estimated by imaging techniques, liver function tests, and endoscopy.

Results. Sixteen patients from 15 families were included. ARPKD was diagnosed between 1 day and 13 years of age. From diagnosis, mean follow-up period lasted 24±9 years. Before age 18, nine patients (56%) were hypertensive, nine (56%) had renal failure, and four (25%) had portal hypertension. Beyond age 18, no additional patient became hypertensive, and another five developed progressive renal insufficiency; altogether, the mean yearly decline of creatinine clearance was 2.9±1.6 ml/min. Portal hypertension was recognized in two additional patients. Four patients experienced gastro-oesophageal bleeding, while recurrent cholangitis or cholangiocarcinoma developed in one case each. At the end of follow-up, 15/16 patients (94%) were alive at a mean age of 27 (18–55) years. Two patients had a normal renal function, 11 had chronic renal insufficiency, one was on regular dialysis, and two had functioning kidney grafts. Four patients had required a porto-systemic shunt.

Conclusions. A subset of ARPKD patients with autonomous renal function at age 18 experiences slowly progressive renal insufficiency. With prolonged renal survival, complications related to portal hypertension are not rare, requiring careful surveillance and appropriate management.

Keywords: adulthood; autosomal recessive polycystic kidney disease; congenital hepatic fibrosis; portal hypertension; renal failure

Correspondence and offprint requests to: Dominique Chauveau MD, Service de Néphrologie, Hôpital Necker, 149 rue de Sèvres, f-75015 Paris, France.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
A. Arbeiter, R. Buscher, K.-E. Bonzel, A.-M. Wingen, U. Vester, J. Wohlschlager, K. Zerres, J. Nurnberger, C. Bergmann, and P. F. Hoyer
Nephrectomy in an autosomal recessive polycystic kidney disease (ARPKD) patient with rapid kidney enlargement and increased expression of EGFR
Nephrol. Dial. Transplant., September 1, 2008; 23(9): 3026 - 3029.
[Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
I. Kim, Y. Fu, K. Hui, G. Moeckel, W. Mai, C. Li, D. Liang, P. Zhao, J. Ma, X.-Z. Chen, et al.
Fibrocystin/Polyductin Modulates Renal Tubular Formation by Regulating Polycystin-2 Expression and Function
J. Am. Soc. Nephrol., March 1, 2008; 19(3): 455 - 468.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
A.-R. Gallagher, E. L. Esquivel, T. S. Briere, X. Tian, M. Mitobe, L. F. Menezes, G. S. Markowitz, D. Jain, L. F. Onuchic, and S. Somlo
Biliary and Pancreatic Dysgenesis in Mice Harboring a Mutation in Pkhd1
Am. J. Pathol., February 1, 2008; 172(2): 417 - 429.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
S. Rossetti and P. C. Harris
Genotype-Phenotype Correlations in Autosomal Dominant and Autosomal Recessive Polycystic Kidney Disease
J. Am. Soc. Nephrol., May 1, 2007; 18(5): 1374 - 1380.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
J.-y. Kaimori, Y. Nagasawa, L. F. Menezes, M. A. Garcia-Gonzalez, J. Deng, E. Imai, L. F. Onuchic, L. M. Guay-Woodford, and G. G. Germino
Polyductin undergoes notch-like processing and regulated release from primary cilia
Hum. Mol. Genet., April 15, 2007; 16(8): 942 - 956.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
S. Wang, J. Zhang, S. M. Nauli, X. Li, P. G. Starremans, Y. Luo, K. A. Roberts, and J. Zhou
Fibrocystin/Polyductin, Found in the Same Protein Complex with Polycystin-2, Regulates Calcium Responses in Kidney Epithelia
Mol. Cell. Biol., April 15, 2007; 27(8): 3241 - 3252.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
S. Wang, Y. Luo, P. D. Wilson, G. B. Witman, and J. Zhou
The Autosomal Recessive Polycystic Kidney Disease Protein Is Localized to Primary Cilia, with Concentration in the Basal Body Area
J. Am. Soc. Nephrol., March 1, 2004; 15(3): 592 - 602.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
L. Furu, L. F. Onuchic, A. Gharavi, X. Hou, E. L. Esquivel, Y. Nagasawa, C. Bergmann, J. Senderek, E. Avner, K. Zerres, et al.
Milder Presentation of Recessive Polycystic Kidney Disease Requires Presence of Amino Acid Substitution Mutations
J. Am. Soc. Nephrol., August 1, 2003; 14(8): 2004 - 2014.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
L. M. Guay-Woodford and R. A. Desmond
Autosomal Recessive Polycystic Kidney Disease: The Clinical Experience in North America
Pediatrics, May 1, 2003; 111(5): 1072 - 1080.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
P. Igarashi and S. Somlo
Genetics and Pathogenesis of Polycystic Kidney Disease
J. Am. Soc. Nephrol., September 1, 2002; 13(9): 2384 - 2398.
[Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
J.-P. Grunfeld, D. Chauveau, and M. Levy
Anderson-Fabry Disease: Its Place among Other Genetic Causes of Renal Disease
J. Am. Soc. Nephrol., June 1, 2002; 13(90002): S126 - 129.
[Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.